Join us in welcoming our 2025 Exact Sciences summer interns! We’re glad you’re here and excited to see the new perspectives you’ll bring to our One Exact team. #WeAreExact
Exact Sciences
Ricerca biotecnologica
Madison, Wisconsin 131.875 follower
Chi siamo
At Exact Sciences, our purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. We're hiring! Our organization offers something for everyone, at all stages of careers and from all backgrounds. Let's take on cancer, together.
- Sito Web
-
http://exactsciences.com
Link esterno per Exact Sciences
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 5001 - 10.000 dipendenti
- Sede principale
- Madison, Wisconsin
- Tipo
- Società quotata
- Settori di competenza
- Precision oncology, Genomic testing, Cancer screening, Genetic testing e Research and development
Località
Dipendenti presso Exact Sciences
Aggiornamenti
-
Results to be presented at #ASCO25 confirm the Oncodetect™ test’s role in supporting treatment and surveillance decisions. Building on this momentum and our commitment to innovation, we look forward to introducing the next generation of the Oncodetect test in 2026. Read more: http://spr.ly/6047N2nsW
-
-
What a thrill it was to see Exact Sciences light up the Nasdaq Tower in Times Square last week to celebrate the launch of the Cologuard Plus™ test! Being featured in the heart of the Big Apple is an honor. The future is bright!
-
We’re sharing data across our expanding portfolio at #ASCO25, demonstrating our commitment to advancing cancer care through scientific excellence. Find out more: http://spr.ly/6042Najrp American Society of Clinical Oncology (ASCO)
-
From developing new therapies to assessing how well a medical test works, clinical trials have a clear impact on patient care. Thank you to all participants and research professionals at Exact Sciences and beyond who make clinical trials possible. Learn more about the clinical trial process with Ali Massoud: http://spr.ly/6047Ntm37 #ClinicalTrialsDay
-
-
🎉 Exciting news out of our Cologuard laboratory: we've officially processed 20 million tests! That’s 20 million results delivered. 20 million opportunities to catch cancer earlier. 20 million reasons to celebrate YOU — the patients, providers, and our amazing team here at Exact Sciences who made this milestone possible. Every test tells a story, and as of today, we’ve been part of 20 million of them. Here's to earlier detection, one test at a time — and to the next 20 million! #Cologuard #GetScreened #ColorectalCancerAwareness
-
📍 Munich, Germany We’re looking forward to sharing how we’re advancing cancer care while connecting with the oncology community this week at #ESMOBreast25. Learn more: http://spr.ly/6045Nbo2V ESMO - European Society for Medical Oncology
-
-
We're proud to be certified as a Great Place To Work® in the U.S. for the seventh consecutive year — and for the first time, we are internationally certified in the UK, Poland, Germany, France, Italy, Japan, and Canada! Shout out to our incredible teams across the globe for their unwavering commitment to creating positive and inclusive workplaces for all. 🔗 http://spr.ly/6043NpBYv #WeAreExact Great Place To Work US
-
Amy’s breast cancer diagnosis was a surprising and scary experience, but she found comfort in hearing the stories of other women who had fought the disease and survived. Now, she shares her own story to support those who are facing a diagnosis. Keep watching: http://spr.ly/6045NyeOD
-
We’re always looking to connect with future team members, whether you're ready for a new role now or in the future! Join the Exact Sciences Talent Community to stay engaged with our recruitment team: http://spr.ly/60472xb71 #WeAreExact
-
Pagine affiliate
Pagine simili
Sfoglia le offerte di lavoro
Azioni
EXAS
NASDAQ
Ritardo di 20 minuti
56,28 USD
-1,34 (-2,326%)
- Apertura
- 57,33
- Minimo
- 56,055
- Massimo
- 57,43
Dati da Refinitiv
Vedi altre informazioni suRaccolta fondi
Ultimo round
Debito post-IPO620.700.000,00 USD